$3.69
+0.290 (+8.53%)
At Close: Jun 04, 2026
The Schall Law Firm Urges Shareholder Participation In An Inquiry Into Treace Medical Concepts, Inc. For Securities Fraud
05:15pm, Sunday, 15'th Dec 2024
LOS ANGELES, CA / ACCESSWIRE / December 15, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Treace Medica
LOS ANGELES, CA / ACCESSWIRE / December 14, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Treace Medica
The Schall Law Firm Encourages Stockholder Participation In An Inquiry Into Treace Medical Concepts, Inc. For Securities Fraud
05:15pm, Friday, 13'th Dec 2024
LOS ANGELES, CA / ACCESSWIRE / December 13, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Treace Medica
LOS ANGELES, CA / ACCESSWIRE / December 12, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Treace Medica
The Schall Law Firm Encourages Shareholder Participation In An Inquiry Into Treace Medical Concepts, Inc. For Securities Fraud
05:45pm, Wednesday, 11'th Dec 2024
LOS ANGELES, CA / ACCESSWIRE / December 11, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Treace Medica
TMCI Investors Have Opportunity to Join Treace Medical Concepts, Inc. Fraud Investigation with the Schall Law Firm
10:49am, Wednesday, 11'th Dec 2024
LOS ANGELES , Dec. 11, 2024 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Treace Medical Conc
LOS ANGELES, CA / ACCESSWIRE / December 10, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Treace Medica
The Schall Law Firm Encourages Shareholder Participation In An Inquiry Into Treace Medical Concepts, Inc. For Securities Fraud
05:45pm, Monday, 09'th Dec 2024
LOS ANGELES, CA / ACCESSWIRE / December 9, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Treace Medical
LOS ANGELES, CA / ACCESSWIRE / December 8, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Treace Medical
The Schall Law Firm Encourages Shareholder Participation In An Inquiry Into Treace Medical Concepts, Inc. For Securities Fraud
06:20pm, Saturday, 07'th Dec 2024
LOS ANGELES, CA / ACCESSWIRE / December 7, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Treace Medical
LOS ANGELES, CA / ACCESSWIRE / December 6, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Treace Medical
The Schall Law Firm Encourages Stockholder Participation In An Inquiry Into Treace Medical Concepts, Inc. For Securities Fraud
10:30am, Thursday, 05'th Dec 2024
LOS ANGELES, CA / ACCESSWIRE / December 5, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Treace Medical
LOS ANGELES, CA / ACCESSWIRE / December 4, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Treace Medical
PONTE VEDRA, Fla., Dec. 04, 2024 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the
Treace Appoints Guy Guglielmino as Chief Commercial Officer
04:15pm, Monday, 02'nd Dec 2024
PONTE VEDRA, Fla., Dec. 02, 2024 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the
Sign In
Buy TMCI